2024

1. Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study

   Clinical and Translational Oncology, Vol. 26, Núm. 8, pp. 1896-1907